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Background: Intravenous (IV) Beta-blockade is not routinely recommended in the early management of patients with ST-Elevation Myocardial 
Infarction (STEMI). We hypothesized that IV beta blockers would improve short
term mortality by reducing infarct size.
methods: PubMed and EMBASE databases were searched from 1965 through 2011. Intervention included intravenous beta-blockers within 12 
hours of presentation followed by reperfusion (either fibrinolysis or PCI). The comparator included standard medical therapy and/or placebo. The 
outcome assessed was the risk of in-hospital all -cause mortality. In-hospital mortality rates were compared using a forest plot of relative risk (RR; 
95% confidence interval [CI]) using a random effects model. Statistical analysis was done with Review Manager V5.1.
results: Eight studies (total N = 8) met the inclusion ⁄exclusion criteria. In-hospital mortality was not reduced with IV beta-blockers administered 
prior to fibrinolysis (N=6), RR = 0.99 (95% CI, 0.86-1.14; p=0.86). However IV beta-blockers before PCI (N=2) showed unequivocal in-hospital 
mortality benefit, RR 0.49 (95% CI, 0.33-0.74; p=0.0006), without statistical heterogeneity-although evidence was available from observational 
studies only.
conclusions: This systematic review appears to indicate an in-hospital mortality benefit with use of IV beta-blockers before PCI early in the course 
of appropriate patients with STEMI.
